Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes

被引:0
|
作者
De Luca, A [1 ]
Vendittelli, M
Boldini, F
Di Giambenedetto, S
Trotta, MP
Cingolani, A
Bacarelli, A
Gori, C
Perno, CF
Antinori, A
Ulivi, G
机构
[1] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy
[2] Univ Roma La Sapienza, Dept Comp & Syst Sci, Rome, Italy
[3] IRCCS, Natl Inst Infect Dis, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[5] Univ Roma Tor Vergata, Dept Comp Sci & Automat, Rome, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To evaluate whether fuzzy operators can be usefully applied to the interpretation of genotypic HIV-1 drug resistance by experts, and to improve the prediction of salvage therapy outcome by adapting interpretation rules of genotypic resistance on the basis of their association with virological response data. Methods: We used a clinical dataset of 231 patients failing highly active antiretroviral therapy (HAART) and starting salvage therapy with baseline resistance genotyping and virological outcomes after 3 and 6 months. A set of rules predicting genotypic resistance was initially derived from an expert (ADL). Rules were implemented using a fuzzy logic approach and the virological outcomes dataset used for the training phase. The resulting algorithm was validated using a separate set of 184 selected patients by correlating the resulting predicted activity with observed virological response at 3 months. For comparison, the expert systems from the drug resistance group of the Agence Nationale de Recherches sur le SIDA (ANRS-AC11) and the algorithm from the Stanford's HIV drug resistance database (Stanford HIVdb) were evaluated on the same set. Results: The starting algorithm had a correlation with virological outcomes of R-2 = 0.06 (P = 0.0001). After the training phase the correlation with virological outcomes increased to R-2 = 0.19 (p < 0.000001). In the validation set of patients, the activity of the salvage regimen predicted by the fuzzy algorithm was the only variable independently predictive of the 3-month viral load change even after adjusting by the activity predicted by the two expert systems and baseline viral load (for each 10% salvage regimen's activity increase, mean HIV RNA change from baseline: -0.27 log(10) copies/ml; 95% CI -0.39, -0.15). Conclusion: Using fuzzy operators in a virological outcomes training database to implement a rules-based algorithm for genotypic resistance interpretation, significant improvements of outcomes prediction were obtained. The resulting algorithm showed an independent predictive capability of virological outcomes over that of two rules-based interpretation algorithms made by experts. Although the system was trained and validated on a limited number of cases, the approach deserves further evaluation.
引用
收藏
页码:583 / 593
页数:11
相关论文
共 50 条
  • [41] Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings
    Armenia, Daniele
    Bouba, Yagai
    Gagliardini, Roberta
    Gori, Caterina
    Bertoli, Ada
    Borghi, Vanni
    Gennari, William
    Micheli, Valeria
    Callegaro, Anna Paola
    Gazzola, Lidia
    Bruzzone, Bianca
    Giannetti, Alberto
    Mazzotta, Valentina
    Vergori, Alessandra
    Mastrorosa, Ilaria
    Colafigli, Manuela
    Lichtner, Miriam
    di Biagio, Antonio
    Maggiolo, Franco
    Rizzardini, Giuliano
    Monforte, Antonella D'Arminio
    Andreoni, Massimo
    Mussini, Cristina
    Antinori, Andrea
    Ceccherini-Silberstein, Francesca
    Perno, Carlo Federico
    Santoro, Maria Mercedes
    JOURNAL OF CLINICAL VIROLOGY, 2020, 130
  • [42] Long-term clinical and viro-immunological outcomes of Argenta, a randomized trial on the usefulness of HIV-1 drug resistance genotyping and expert advice
    Cingolani, A
    Di Giambenedetto, S
    Bacarelli, A
    Murri, R
    Ammassari, A
    Cauda, R
    De Luca, A
    ANTIVIRAL THERAPY, 2003, 8 (03) : U106 - U107
  • [43] Open ORIGINAL RESEARCH Risk Factors of Drug Resistance and the Potential Risk of HIV-1 Transmission of Patients with ART Virological Failure: A Population-Based Study in Sichuan, China
    Zhou, Chang
    Kang, Rui
    Liang, Shu
    Fei, Teng
    Li, Yiping
    Su, Ling
    Li, Ling
    Ye, Li
    Zhang, Yan
    Yuan, Dan
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 5219 - 5233
  • [44] Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
    Capina, Rupert
    Li, Katherine
    Kearney, Levon
    Vandamme, Anne-Mieke
    Harrigan, P. Richard
    Van Laethem, Kristel
    VIRUSES-BASEL, 2020, 12 (06):
  • [45] HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya
    Nyandiko, Winstone
    Holland, Sabina
    Vreeman, Rachel
    DeLong, Allison K.
    Manne, Akarsh
    Novitsky, Vladimir
    Sang, Festus
    Ashimosi, Celestine
    Ngeresa, Anthony
    Chory, Ashley
    Aluoch, Josephine
    Orido, Millicent
    Jepkemboi, Eslyne
    Sam, Soya S.
    Caliendo, Angela M.
    Ayaya, Samuel
    Hogan, Joseph W.
    Kantor, Rami
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 89 (02) : 231 - 239
  • [46] Second Generation Next-generation Sequencing-based System for Detecting Drug Resistance Mutations in HIV-1 Combined with Isothermal Amplification
    Wee, E. J.
    Ng, Y.
    Suhardi, H.
    Villy, C.
    Ariyaratne, P.
    Lye, W.
    Tan, G. S.
    Fan, A.
    Kng, N.
    Luo, R.
    Ng, I.
    Michel, G.
    Lee, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 936 - 936
  • [47] Impact of genotypic diversity on selection of subtype-specific drug resistance profiles during raltegravir-based therapy in individuals infected with B and BF recombinant HIV-1 strains
    Sanchez, Daniela
    Arazi Caillaud, Solange
    Zapiola, Ines
    Fernandez Giuliano, Silvina
    Bologna, Rosa
    Mangano, Andrea
    Aulicino, Paula C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1567 - 1574
  • [48] Differences of nine drug resistance interpretation systems in predicting short-term therapy outcomes of treatment-experienced HIV-1 infected patients: A retrospective observational cohort study
    Helm, M.
    Walter, H.
    Ehret, R.
    Schmit, J-C
    Kurowski, M.
    Knechten, H.
    Korn, K.
    Braun, P.
    Schmidt, B.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (06) : 231 - 242
  • [49] An Innovative Sequence-to-Structure-Based Approach to Drug Resistance Interpretation and Prediction: The Use of Molecular Interaction Fields to Detect HIV-1 Protease Binding-Site Dissimilarities
    Alves, Nuno G.
    Mata, Ana I.
    Luis, Joao P.
    Brito, Rui M. M.
    Simoes, Carlos J. V.
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [50] Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study
    Porter, Danielle P.
    Toma, Jonathan
    Tan, Yuping
    Solberg, Owen
    Cai, Suqin
    Kulkarni, Rima
    Andreatta, Kristen
    Lie, Yolanda
    Chuck, Susan K.
    Palella, Frank
    Miller, Michael D.
    White, Kirsten L.
    HIV CLINICAL TRIALS, 2016, 17 (01): : 29 - 37